Definition/General

Introduction:
-Acinic cell carcinoma is a malignant epithelial tumor composed of cells resembling serous acinar cells of salivary glands
-Represents 10-15% of all salivary gland malignancies
-Characterized by granular, basophilic cytoplasm containing zymogen-like granules
-Shows variable morphological patterns and generally indolent behavior.
Origin:
-Arises from acinar cells or intercalated duct cells with acinar differentiation
-Maintains serous acinar phenotype
-Secretory granules contain amylase and other enzymes
-May arise from pre-existing pleomorphic adenoma
-Shows acinar cell differentiation markers.
Classification:
-WHO Classification: Acinic cell carcinoma
-Milan System: Category V or VI (Suspicious/Malignant)
-Histological patterns: solid, microcystic, papillary-cystic, follicular
-No standard grading system
-High-grade transformation can occur.
Epidemiology:
-Accounts for 10-15% of salivary gland malignancies
-Wide age range with peak in 4th-5th decades
-Slight female predominance
-Parotid gland most common site (90%)
-Bilateral occurrence in 5% cases
-Indian population shows similar demographic patterns.

Clinical Features

Presentation:
-Slowly growing, painless mass
-Usually well-circumscribed
-Size typically 2-6 cm
-May be multinodular
-Rarely causes facial nerve paralysis
-Mobile on palpation initially.
Symptoms:
-Usually asymptomatic in early stages
-Mild pain (20-30% cases)
-Swelling main complaint
-Rarely causes facial weakness
-No functional salivary impairment
-Regional lymphadenopathy uncommon.
Risk Factors:
-Female gender (slight predominance)
-Middle age
-Prior radiation exposure (weak association)
-No association with smoking or alcohol
-Genetic predisposition not established
-Autoimmune conditions (minimal association).
Screening:
-Clinical examination for parotid masses
-Bilateral palpation important
-Imaging: ultrasound first-line
-MRI/CT for detailed assessment
-FNAC for cytological diagnosis
-Functional assessment of facial nerve.

Master Acinic Cell Carcinoma FNAC Pathology with RxDx

Access 100+ pathology videos and expert guidance with the RxDx app

Gross Description

Appearance:
-FNAC aspirate typically moderately to highly cellular
-Clear to slightly turbid appearance
-Volume usually 1-3 ml
-May be slightly viscous
-Contains cellular aggregates.
Characteristics:
-Fluid consistency thin to moderate
-May contain tissue fragments
-Absence of mucoid material
-May be blood-tinged
-Contains abundant cellular material.
Size Location:
-Usually yields adequate cellular material
-Multiple passes may show different patterns
-Superficial tumors easily sampled
-Deep lobe tumors may need imaging guidance
-Sample quality generally good.
Multifocality:
-Usually unifocal tumor
-Bilateral occurrence possible (5%)
-May be multinodular within gland
-Rarely shows lymph node metastases
-Local recurrence if incompletely excised.

Microscopic Description

Histological Features:
-Cells resembling normal acinar cells with granular cytoplasm
-Basophilic, granular cytoplasm containing zymogen-like granules
-Round to oval nuclei with fine chromatin
-Variable architectural patterns
-PAS-positive granules (diastase resistant).
Cellular Characteristics:
-Large cells with abundant cytoplasm
-Cytoplasm is finely granular and basophilic
-Eccentric nuclei with fine chromatin
-Small, inconspicuous nucleoli
-May show clear cell change
-Vacuolated cytoplasm in some cells.
Architectural Patterns:
-Solid pattern: sheets and clusters of cells
-Microcystic pattern: small cystic spaces
-Papillary-cystic pattern: papillary projections
-Follicular pattern: thyroid-like appearance
-Mixed patterns common in single specimen.
Grading Criteria:
-No standard grading system
-Nuclear morphology generally bland
-Mitotic activity low to moderate
-High-grade transformation shows pleomorphism
-Necrosis uncommon
-Overall architecture maintained.

Immunohistochemistry

Positive Markers:
-Amylase positive (characteristic)
-PAS positive (diastase resistant)
-CK7 positive
-EMA positive
-GCDFP-15 positive
-Lysozyme positive
-Lactoferrin positive
-DOG-1 positive (subset).
Negative Markers:
-S-100 negative
-Chromogranin negative
-Synaptophysin negative
-Thyroglobulin negative
-CD117 negative
-p63 negative
-SMA negative
-TTF-1 negative.
Diagnostic Utility:
-Amylase positivity characteristic feature
-PAS stain highlights zymogen granules
-Helps distinguish from other granular cell tumors
-CK7 confirms epithelial nature
-Ki-67 index typically low (<10%)
-DOG-1 positive in subset of cases.
Molecular Subtypes:
-No specific molecular subtypes recognized
-NR4A3 rearrangements in subset of high-grade cases
-HTN3-MSANTD3 fusion rarely described
-Most cases show no specific alterations
-Copy number changes in aggressive variants.

Molecular/Genetic

Genetic Mutations:
-Generally genetically stable tumors
-NR4A3 rearrangements in high-grade transformation
-TP53 mutations in aggressive variants
-HRAS mutations occasionally
-PIK3CA mutations rare
-Chromosomal gains/losses in some cases.
Molecular Markers:
-NR4A3 (NOR1) rearrangements detectable by FISH
-Amylase gene expression maintained
-Acinar differentiation markers preserved
-Low proliferation indices
-Intact DNA repair mechanisms
-Normal apoptotic pathways.
Prognostic Significance:
-Generally good prognosis with complete excision
-10-year survival 80-90%
-Local recurrence if incomplete excision
-Distant metastases rare (5-10%)
-High-grade transformation worsens prognosis
-Late recurrences possible (>10 years).
Therapeutic Targets:
-Surgical excision primary treatment
-Radiation therapy for high-grade or recurrent tumors
-Targeted therapy limited options
-Immunotherapy under investigation
-Clinical trials for recurrent disease
-Long-term follow-up essential.

Differential Diagnosis

Similar Entities:
-Normal acinar cells (reactive/hyperplastic)
-Oncocytoma (mitochondrial granules)
-Pleomorphic adenoma (chondromyxoid matrix)
-Clear cell carcinoma (clear cytoplasm)
-Granular cell tumor (S-100 positive)
-Metastatic renal cell carcinoma.
Distinguishing Features:
-Acinic cell: Amylase positive
-PAS-positive granules
-Basophilic cytoplasm
-Oncocytoma: Mitochondrial stains
-Eosinophilic cytoplasm
-Normal acinar: Benign morphology
-Context-dependent
-Pleomorphic adenoma: Matrix component
-Mixed cell types
-Granular cell tumor: S-100 positive
-Different location.
Diagnostic Challenges:
-Clear cell variant may be difficult
-Distinction from normal acinar tissue
-Oncocytic change may be confusing
-Microcystic pattern mimics other tumors
-Follicular pattern resembles thyroid
-High-grade areas may lose typical features.
Rare Variants:
-Clear cell variant: glycogen-rich cells
-Oncocytic variant: mitochondrial-rich cells
-Lymphoepithelial variant: prominent lymphoid infiltrate
-Papillary-cystic variant
-Dedifferentiated acinic cell carcinoma
-High-grade transformation.

Sample Pathology Report

Template Format

Sample Pathology Report

Complete Report: This is an example of how the final pathology report should be structured for this condition.

Specimen Information

Fine needle aspiration from parotid gland mass

Specimen Adequacy

Adequate for evaluation - contains representative tumor cells

Cellular Composition

Uniform population of cells with granular, basophilic cytoplasm

Morphological Features

Acinar-type cells with abundant granular cytoplasm and round nuclei

Cytoplasmic Granules

Basophilic, zymogen-like granules throughout cytoplasm

Architectural Pattern

Predominantly [solid/microcystic/papillary-cystic] pattern

Background

Clean cellular background with scattered single cells

Milan System Category

Category VI - Malignant

Cytological Diagnosis

Acinic cell carcinoma

Recommendation

Histopathological correlation recommended. PAS/amylase stains suggested